Literature DB >> 31142488

Atypical presentation of necrotising autoimmune myopathy.

Oyintayo Ajiboye1, Michelle Manesh2, Nisar Asmi1, Benjamin Mba1.   

Abstract

Necrotising autoimmune myopathy (NAM) is characterised by a common phenotype of profound symmetrical proximal muscle weakness, elevated creatine kinase levels, irritable myopathy on electromyography and histological findings of myocyte necrosis and regeneration without remarkable inflammation. NAM is associated with autoimmune antibodies including anti-3-hydroxy-3-methylglutaryl-coenzyme receptor, which is strongly associated with statin use. We report a case of statin-associated NAM with an atypical presentation of severe oropharyngeal dysphagia and no remarkable proximal muscle weakness at initial presentation but with rapid progression to severe quadriparesis in weeks. This case expands the spectrum of presentation patterns of this rare disease and highlights the need for a high index of suspicion in patients with a remote history of statin use. © BMJ Publishing Group Limited 2019. No commercial re-use. See rights and permissions. Published by BMJ.

Entities:  

Keywords:  connective tissue disease; drugs: musculoskeletal and joint diseases; musculoskeletal syndromes

Mesh:

Substances:

Year:  2019        PMID: 31142488      PMCID: PMC6557363          DOI: 10.1136/bcr-2018-229119

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  9 in total

1.  Statin-associated immune-mediated necrotizing myopathy: a retrospective analysis of individual case safety reports from VigiBase.

Authors:  Dirk Essers; Martina Schäublin; Gerd A Kullak-Ublick; Stefan Weiler
Journal:  Eur J Clin Pharmacol       Date:  2018-11-15       Impact factor: 2.953

Review 2.  Immune-Mediated Necrotizing Myopathy: Update on Diagnosis and Management.

Authors:  Pari Basharat; Lisa Christopher-Stine
Journal:  Curr Rheumatol Rep       Date:  2015-12       Impact factor: 4.592

3.  Autoantibodies against 3-hydroxy-3-methylglutaryl-coenzyme A reductase in patients with statin-associated autoimmune myopathy.

Authors:  Andrew L Mammen; Tae Chung; Lisa Christopher-Stine; Paul Rosen; Antony Rosen; Kimberly R Doering; Livia A Casciola-Rosen
Journal:  Arthritis Rheum       Date:  2011-03

Review 4.  Immune-mediated necrotizing myopathy.

Authors:  C Bergua; H Chiavelli; J P Simon; O Boyer; F Jouen; W Stenzel; J Martinet
Journal:  Z Rheumatol       Date:  2016-03       Impact factor: 1.372

Review 5.  Statin-induced necrotizing myositis - a discrete autoimmune entity within the "statin-induced myopathy spectrum".

Authors:  Philip D H Hamann; Robert G Cooper; Neil J McHugh; Hector Chinoy
Journal:  Autoimmun Rev       Date:  2013-07-11       Impact factor: 9.754

Review 6.  Classification and management of adult inflammatory myopathies.

Authors:  Albert Selva-O'Callaghan; Iago Pinal-Fernandez; Ernesto Trallero-Araguás; José César Milisenda; Josep Maria Grau-Junyent; Andrew L Mammen
Journal:  Lancet Neurol       Date:  2018-09       Impact factor: 44.182

Review 7.  Immune-mediated necrotizing myopathy associated with statins: history and recent developments.

Authors:  Eleni Tiniakou; Lisa Christopher-Stine
Journal:  Curr Opin Rheumatol       Date:  2017-11       Impact factor: 5.006

8.  Immune-mediated necrotizing myopathy associated with statins.

Authors:  Phyllis Grable-Esposito; Hans D Katzberg; Steven A Greenberg; Jayashri Srinivasan; Jonathan Katz; Anthony A Amato
Journal:  Muscle Nerve       Date:  2010-02       Impact factor: 3.217

9.  Statins and myotoxic effects associated with anti-3-hydroxy-3-methylglutaryl-coenzyme A reductase autoantibodies: an observational study in Japan.

Authors:  Yurika Watanabe; Shigeaki Suzuki; Hiroaki Nishimura; Ken-Ya Murata; Takashi Kurashige; Masamichi Ikawa; Masaru Asahi; Hirofumi Konishi; Satsuki Mitsuma; Satoshi Kawabata; Norihiro Suzuki; Ichizo Nishino
Journal:  Medicine (Baltimore)       Date:  2015-01       Impact factor: 1.889

  9 in total
  1 in total

Review 1.  Statin-induced necrotizing autoimmune myopathy: a systematic review.

Authors:  Manoj Kumar Reddy Somagutta; Nishat Shama; Maria Kezia Lourdes Pormento; Ravi Pankajbhai Jagani; Ngaba Neguemadji Ngardig; Klodin Ghazarian; Greta Mahmutaj; Khaled El-Faramawy; Ashwini Mahadevaiah; Molly Sanjay Jain
Journal:  Reumatologia       Date:  2022-02-28
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.